Shares of IBM IBM rose in early trading on Thursday, after the company reported better-than-expected earnings for the first quarter.
Bernstein On IBM
Analyst Toni Sacconaghi maintained a Market-Perform rating and price target of $145.
IBM's first-quarter results were broadly in-line with the consensus estimates, Sacconaghi said in a note. “As expected, IBM reaffirmed its FY 2023 revenue and FCF targets, though it did broaden its expected revenue growth range to 3% - 5%,” he added.
IBM indicated a deceleration in consulting demand in the U.S., while there is no erosion in its consulting backlog, the analyst mentioned. “We note that Consulting historically has been a cyclical business, and we see some risk to 2H revenues from a potentially weaker macro environment,” he added.
Check out other analyst stock ratings.
Morgan Stanley On IBM
Analyst Erik Woodring reiterated an Equal-Weight rating, while reducing the price target from $143 to $135.
“IBM beat 1Q EPS and kept CY23 rev growth largely unchanged at 3-5% Y/Y in CC & $10.5B FCF, reflecting lower growth in Consulting and RHT, but stronger TPP,” Woodring said in a note.
Although IBM’s first-quarter results were better than feared, it needs a “strong 2H ramp” to meet its only slightly lowered earnings guidance for 2023, the analyst stated. “Lowered Consulting outlook reflects end of 1Q deterioration,” he added.
IBM Price Action: Shares of IBM had risen by 0.69% to $127.19 at the time of publishing Thursday.
Also Read: SpaceX Starship Launches, Boosters Fail To Separate: What Elon Musk Has To Say For Future
Photo: Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.